NSE · Basic Materials · Specialty Chemicals
EPS came in at 15.24 against a street estimate of 11.07 — a beat of 37.7%.
with an average price target of ₹3,649.67.
CONFIDENT Acutaas delivered strong Q2 growth, raised FY27 revenue and EBITDA margin guidance, and accelerated its CDMO target while specialty chemicals remain in transition. Q2 FY27 Export markets are the current focus for semiconductor chemicals; Indian semiconductor demand is expected to develop later. Analysts focused on CDMO visibility, product diversification, utilization, electrolyte pricing and semiconductor ramp-up. Management emphasized long-term contracts, multiple pipeline products and gradual qualification-led growth. 2026-10-27…
Full summary in the app.
| Holder | Stake |
|---|---|
| Dhwani Girishkumar Chovatia | 3.35% |
| Government Pension Fund Global | 3.11% |
| Kotak Mahindra Trustee CO Ltd A/C Kotak Nifty Alpha 50 Index Fund | 2.86% |
| Axis Max Life Insurance Limited A/C Nifty Momentum Quality 50 Fund | 2.04% |
| SBI Nifty Smallcap 250 Index Fund | 1.83% |
| Document | Date |
|---|---|
| Annual report FY2026 ACUTAAS CHEMICALS LIMITED - ANNUAL REPORT FY2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations (Consolidated): ₹13,394 Million in FY2026, up | 2026-08-29 |
| Investor presentation · Q1 FY27 ACUTAAS CHEMICALS LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Q1 FY27 Revenue: ₹3,297 Mn, up 59.1% YoY (from ₹2,072 Mn in Q1 FY26) • Q1 FY27 EBITD | 2026-07-24 |
| Quarterly results · Q1 FY27 ACUTAAS CHEMICALS LIMITED - Q1 FY2027 RESULTS SUMMARY HEADLINE NUMBERS • Revenue from Operations (Q1 FY2027): ₹32,967.48 lakhs (consolidated), ₹32,2 | 2026-07-24 |
| Investor presentation · Q4 FY26 ACUTAAS CHEMICALS LIMITED - INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Revenue: ₹13,394 Mn (from operations: ₹11,741 Mn pharmaceutical + ₹1,652 Mn spe | 2026-05-16 |
| Q4 FY26 earnings call ACUTAAS CHEMICALS LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • FY26 Revenue: INR 1,339.4 crores (33% YoY growth) • FY26 PAT: INR 356.4 crores (more | 2026-05-06 |
| Quarterly results · Q4 FY26 ACUTAAS CHEMICALS LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • FY 2025-26 Revenue from Operations: Rs. 133,936.68 lakhs (₹1,339.37 crores) vs. ₹100 | 2026-04-30 |
| Investor presentation | 2026-04-30 |
| Q3 FY26 earnings call ACUTAAS CHEMICALS LIMITED – Q3 FY26 SUMMARY HEADLINE NUMBERS • Q3 FY26 Revenue from Operations: INR 393.2 crores, up 43% Y-o-Y • Q3 FY26 Gross Profi | 2026-02-03 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹2.50 / share ex-date Sep 17, 2026 | 2026-09-17 |
| Announcement | Date |
|---|---|
| Acquisition announced by Acutaas Chemicals Limited Acutaas Chemicals completed the transfer of 100% of Enchem Ami Organics Private Limited’s equity shares from its existing subsidiary, Acutaas Chemicals Electrolytes Private Limited. The tran | 2026-10-17 |
| Acquisition of another business completed Acutaas Chemicals Limited announced the acquisition of 100% equity stake in Enchem Ami Organics Private Limited (EAOPL), its step-down subsidiary, for Rs. 1,00,000 (one lakh rupees). Current | 2026-09-24 |
| Update on acquisition of another business or strategic partnership Acutaas Chemicals Limited has informed the Exchange about update on acquisition | 2026-02-11 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for ACUTAAS CHEMICALS LTD — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.